PHARMACOEPIDEMIOLOGY 4E
商品資訊
ISBN13:9780470866818
出版社:JOHN WILEY & SONS;LTD
作者:STROM
出版日:2005/08/12
裝訂/頁數:精裝/910頁
商品簡介
Reviews of previous editions of his celebrated textbook include:
"The book is essential reading for anyone interested in pharmacoepidemiology."
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
“…an excellent textbook and a comprehensive reference which belongs in the library of every pharmaceutical manufacturer and regulator."
EUROPEAN JOURNAL OF PUBLIC HEALTH
目次
Preface.
Acknowledgments.
PART
1. What is Pharmacoepidemiology (Brian L. Strom)?
2. Study Design Available for Pharmacoepidemiology Studies (Brian L. Strom).
3. Sample Size Considerations for Pharmacoepidemiology Studies (Brian L. Strom).
4. Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiology Studies (David A. Henry, Patricia McGettigan, Anne Tonkin and Sean Hennessy).
5. When Should One Perform Pharmacoepidemiology Studies (Brian L. Strom)?
PART II. PERSPECTIVES ON PHARMACOEPIDEMIOLOGY.
6. A View from Academia (Robert M. Califf and Leanne K. Madre).
7. A View from Industry (Robert F. Reynolds, Dale B. Glasser and Gretchen S. Dieck).
8. A View from Regulatory Agencies (Peter Arlett, Jane Moseley and Paul J. Sedigman).
PART III. SOURCES OF DATA FOR PHARMACOEPIDEMIOLOGY STUDIES.
PART IIIa. Ad Hoc Data Sources Available for Pharmacoepidemiology Studies.
9. Spontaneous Reporting in the
10. Global Drug Surveillance: The WHO Programme for International Drug Monitoring (
11. Case-Control Surveillance (Lynn Rosenberg, Patricia F. Coogan and Juliet R. Palmer).
12. Prescription-Event Monitoring (Saad A. W. Shakir).
PART IIIb Automated Data Systems Available for Pharmacoepidemiology Studies.
13. Overview of Automated Databases in Pharmacoepidemiology (Brian L. Strom).
14. Group-Health Cooperative (Kathleen W. Saunders, Robert L. Davis and Andy Stergachis).
15. Kaiser Permanente Medical Care Program (Joe V. Selby, David H. Smith, Eric S. Johnson, Marsha A. Raebel, Gary D. Friedman and Bentson H. McFarland).
16. The HMO Research Network (K.nold Chan, Robert L.el, Douglas W. Roblin, David H. Smith and Richard Platt).
17. UnitedHealth Group (Deborah Shatin, Nigel S. B. Rawson and Andy Stergachis).
18. Medicaid Databases (Sean Hennessy, Jeffrey L. Carson, Wayne A. Ray and Brian L. Strom).
19. Health Services Databases in
20. Automated Pharmacy Record Linkage in the
21. The Tayside Medicines Monitoring Unit (MEMO) (Li Wei, John Parkinson and Thomas M. MacDonald).
22. The
PART IIIc. Other Approaches to Pharmacoepidemiology Studies.
23. Other Approaches to Pharmacoepidemiology Studies (Brian L. Strom).
24. How Should One Perform Pharmacoepidemiology Studies? Choosing Among the Available Alternatives (Brian L. Strom).
PART IV. SELECTED SPECIAL APPLICATIONS OF PHARMACOEPIDEMIOLOGY.
25. National Medicinal Drug Policies: Their Relationship to Pharmacoepidemiology (Suzanne Hill and David A. Henry).
26. Premarketing Applications of Pharmacoepidemiology (Harry A. Guess).
27. Studies of Drug Utilization (David Lee and Ulf Bergman).
28. Evaluating and Improving Physician Prescribing (Sumit R. Majumdar, Helene Levens Lipton and Stephen B. Soumerai).
29. Drug Utilization Review (Sean Hennessey, Stephen B. Soumerai, Helene Levens Lipton and Brian L. Strom).
30. Special Methodological Issues in Pharmacoepidemiology Studies of Vaccine Safety (Robert T. Chen, Robert L. Davis and Philip H. Rhodes).
31. Pharmacoepidemiologic Studies of Devices (Roselie A. Bright).
32. Studies of Drug-Induced Birth Defects (Allen A. Mitchell).
33. Pharmacoepidemiology and Risk Management (David J. Graham, Andrew D. Mosholder, Kate Gelperin and Mark I. Avigan).
34. The Use of Pharmacoepidemiology to Study Medication Errors (Rainu Kaushal and David W. Bates).
PART V. SELECTED SPECIAL METHODOLOGIC ISSUES IN PHARMACOEPIDEMIOLOGY.
36. Determining Causation from Case Report (Judith K. Jones).
37. Molecular Pharmacoepidemiology (Stephen E. Kimmel, Hubert G. Leufkens and Timothy R. Rebbeck).
38. Bioethical Issues in Pharmacoepidemiology Research (David Casarett, Jason Karlawish, Elizabeth Andrews and Arthur Caplan).
39. The Use of Randomized Controlled Trials for Pharmacoepidemiology Studies (Samuel M. Lesko and Allen A. Mitchell).
40. The Use of Pharmacoepidemiology to Study Beneficial Drug Effects (Brian L. Strom and the late Kenneth L. Melmon).
41. Pharmacoeconomics: Economic Evaluation of Pharmaceuticals (Kevin A. Schulman, Henry A. Glick and Daniel Polsky).
42. Using Quality-of-Life Measurements in Pharmacoepidemiologic Research (Holger Schünemann, Gordon H. Guyatt and Roman Jaeschke).
43. N-of-1 Randomized Clinical Trials in Pharmacoepidemiology (Gordon H. Guyatt, Roman Jaeschke and Robin Roberts).
44. The Use of Meta-Analysis in Pharmacoepidemiology (Jesse A. Berlin and Carin J. Kim).
45. Validity of Pharmacoepidemiologic Drug and Diagnosis Data (Suzanne L. West, Brian L. Strom and Charles Poole).
46. Variable Compliance and Persistence with Prescribed Drug Doing Regimens: Implications for Benefits, Risks, and Economics of Pharmacotherapy (John Urquhart).
47. Bias and Confounding in Pharmacoepidemiology (Ilona Csizmadi, Jean-Paul Collet and Jean-François Boivin).
48. Novel Approaches to Pharmacoepidemiology Study Design and Statistical Analysis (Samy Suissa).
PART IV. CONCLUSION.
49. The Future of Pharmacoepidemiology (Brian L. Strom and Sean Hennessy).
Appendix A: Sample Size Tables.
Appendix B: Glossary.
Index.
相關商品
主題書展
更多書展今日66折
您曾經瀏覽過的商品
購物須知
外文書商品之書封,為出版社提供之樣本。實際出貨商品,以出版社所提供之現有版本為主。部份書籍,因出版社供應狀況特殊,匯率將依實際狀況做調整。
無庫存之商品,在您完成訂單程序之後,將以空運的方式為你下單調貨。為了縮短等待的時間,建議您將外文書與其他商品分開下單,以獲得最快的取貨速度,平均調貨時間為1~2個月。
為了保護您的權益,「三民網路書店」提供會員七日商品鑑賞期(收到商品為起始日)。
若要辦理退貨,請在商品鑑賞期內寄回,且商品必須是全新狀態與完整包裝(商品、附件、發票、隨貨贈品等)否則恕不接受退貨。